0001209191-19-054300.txt : 20191028
0001209191-19-054300.hdr.sgml : 20191028
20191028214704
ACCESSION NUMBER: 0001209191-19-054300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191028
FILED AS OF DATE: 20191028
DATE AS OF CHANGE: 20191028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ward Anne Sempowski
CENTRAL INDEX KEY: 0001790117
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34186
FILM NUMBER: 191174328
MAIL ADDRESS:
STREET 1: C/O VANDA PHARMACEUTICALS INC.
STREET 2: 2200 PENNSYLVANIA AVENUE, SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001347178
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030491827
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
BUSINESS PHONE: 202-734-3400
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-28
0
0001347178
Vanda Pharmaceuticals Inc.
VNDA
0001790117
Ward Anne Sempowski
C/O VANDA PHARMACEUTICALS INC.
2200 PENNSYLVANIA AVENUE, SUITE 300E
WASHINGTON
DC
20037
1
0
0
0
Stock Option (right to buy)
14.21
2019-10-28
4
A
0
35000
0.00
A
2029-10-27
Common Stock
35000
35000
D
The option vests with respect to 25% of the underlying shares when the Reporting Person completes 12 months of continuous service following the date of grant, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.
/s/ Anne Sempowski Ward
2019-10-28